A Phase 4, Multicenter, Open-label, Efficacy and Safety Trial of Pegloticase and Methotrexate Co-administered in Patients with Uncontrolled Gout who have Previously Received Pegloticase Monotherapy but did not Maintain a Serum Uric Acid Response
Details
Age
Adult
Type of Study
Treatment
Locations
Barbara Davis Center
University of Colorado Hospital
Principal Investigator
Christopher Striebich, MD, PhD
Study ID
Protocol Number: 21-3601
More information available at ClinicalTrials.gov: NCT04772313
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers